Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization

G. Dangas, A. Colombo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Coronary dissections and intracoronary thrombosis are the most important determinants of acute and subacute complications occurring during coronary interventions. Stents have proved efficacious to repair coronary dissections. The formation of intracoronary thrombi during percutaneous coronary intervention (PCI), the other main pathogenic mechanism for acute complications of PCI, has also been implicated in the pathogenesis of long- term ischemic outcomes. To reduce intracoronary thrombosis, all PCIs have been historically performed during intense short-term anticoagulation with the combination of unfractionated heparin plus aspirin. Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI.

Original languageEnglish
JournalAmerican Heart Journal
Volume138
Issue number1 II
DOIs
Publication statusPublished - 1999

Fingerprint

Integrin beta3
Platelet Glycoprotein GPIIb-IIIa Complex
Percutaneous Coronary Intervention
Thrombosis
Dissection
Platelet Aggregation Inhibitors
Aspirin
Stents
Heparin
Blood Platelets

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization. / Dangas, G.; Colombo, A.

In: American Heart Journal, Vol. 138, No. 1 II, 1999.

Research output: Contribution to journalArticle

@article{2628951be5244b81a61ae0a3fbb01b7f,
title = "Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization",
abstract = "Coronary dissections and intracoronary thrombosis are the most important determinants of acute and subacute complications occurring during coronary interventions. Stents have proved efficacious to repair coronary dissections. The formation of intracoronary thrombi during percutaneous coronary intervention (PCI), the other main pathogenic mechanism for acute complications of PCI, has also been implicated in the pathogenesis of long- term ischemic outcomes. To reduce intracoronary thrombosis, all PCIs have been historically performed during intense short-term anticoagulation with the combination of unfractionated heparin plus aspirin. Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI.",
author = "G. Dangas and A. Colombo",
year = "1999",
doi = "10.1053/hj.1999.v138.99077",
language = "English",
volume = "138",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1 II",

}

TY - JOUR

T1 - Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary revascularization

AU - Dangas, G.

AU - Colombo, A.

PY - 1999

Y1 - 1999

N2 - Coronary dissections and intracoronary thrombosis are the most important determinants of acute and subacute complications occurring during coronary interventions. Stents have proved efficacious to repair coronary dissections. The formation of intracoronary thrombi during percutaneous coronary intervention (PCI), the other main pathogenic mechanism for acute complications of PCI, has also been implicated in the pathogenesis of long- term ischemic outcomes. To reduce intracoronary thrombosis, all PCIs have been historically performed during intense short-term anticoagulation with the combination of unfractionated heparin plus aspirin. Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI.

AB - Coronary dissections and intracoronary thrombosis are the most important determinants of acute and subacute complications occurring during coronary interventions. Stents have proved efficacious to repair coronary dissections. The formation of intracoronary thrombi during percutaneous coronary intervention (PCI), the other main pathogenic mechanism for acute complications of PCI, has also been implicated in the pathogenesis of long- term ischemic outcomes. To reduce intracoronary thrombosis, all PCIs have been historically performed during intense short-term anticoagulation with the combination of unfractionated heparin plus aspirin. Compelling data on the central role of platelets in arterial thrombosis have made apparent the need for more potent antiplatelet agents for the treatment of patients undergoing PCI.

UR - http://www.scopus.com/inward/record.url?scp=0032781824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032781824&partnerID=8YFLogxK

U2 - 10.1053/hj.1999.v138.99077

DO - 10.1053/hj.1999.v138.99077

M3 - Article

C2 - 10385787

AN - SCOPUS:0032781824

VL - 138

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1 II

ER -